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Abstract
Single nucleotide polymorphisms (SNPs) are the most commonly used polymorphic markers in genetics studies. Among the
different platforms for SNP genotyping, Luminex is one of the less exploited mainly due to the lack of a robust (semi-
automated and replicable) freely available genotype calling software. Here we describe a clustering algorithm that provides
automated SNP calls for Luminex genotyping assays. We genotyped 3 SNPs in a cohort of 330 childhood leukemia patients,
200 parents of patient and 325 healthy individuals and used the Automated Luminex Genotyping (ALG) algorithm for SNP
calling. ALG genotypes were called twice to test for reproducibility and were compared to sequencing data to test for
accuracy. Globally, this analysis demonstrates the accuracy (99.6%) of the method, its reproducibility (99.8%) and the low
level of no genotyping calls (3.4%). The high efficiency of the method proves that ALG is a suitable alternative to the current
commercial software. ALG is semi-automated, and provides numerical measures of confidence for each SNP called, as well
as an effective graphical plot. Moreover ALG can be used either through a graphical user interface, requiring no specific
informatics knowledge, or through command line with access to the open source code. The ALG software has been
implemented in R and is freely available for non-commercial use either at http://alg.sourceforge.net or by request to
mathieu.bourgey@umontreal.ca
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Introduction
A single nucleotide polymorphism (SNP) is a DNA sequence
variation that occurs at a single nucleotide position in the genome. As
genotyping has become less expensive, it has become common to
attempt to map disease genes via genome-wide scans [1]. Moreover,
SNPs are the most commonly used polymorphic markers to identify
candidate genes for complex diseases in genetic epidemiology studies
[2,3]. Genotyping errors are inherent to both family-based and case-
control genetic association studies [4,5,6] and can lead to biased
allelic and genotypic frequencies and thus either increases type I error
rates [4,7,8] and decreases in power [9,10]. In the case of candidate
gene studies, the LuminexH 100/200 xMap technology (Austin, TX)
is relatively inexpensive and easy to operate and maintain. With 100
separate identifiable beads available, a theoretical maximum of 50
different mutations can be assayed simultaneously on this platform
[11]. This medium throughput SNP Genotyping system is ideal in
clinical facilities for all sorts of genotyping applications, including
pharmacogenomics [12,13,14] and medical genetic applications
[15,16] as well as population genetics [17,18].
On the other hand, an important limitation of the Luminex
genotyping platform is the lack of a freely available automated
genotype calling software. The commercial STarStation/STar-
Base SNP or MasterPlex GT V2.3 analysis softwares can be
purchased respectively from Applied CytometryH (Sheffield, UK)
and MiraiBioH (San Francisco, USA); otherwise, genotypes must
be called manually, which could incur substantial increases in time
and in genotype errors due to user subjectivity and human error.
In response to the need for additional Luminex genotype calling
software, we have developed the Automated Luminex Genotyping
(ALG) software package that allows for extensive genotype calling
from Luminex assays using either a friendly graphical user
interface (GUI) or a command line interface in R. As we describe
here, the ALG software is efficient and provides internal quality
controls, and is an ideal alternative to the current commercial
software. These properties have been confirmed by the blind
analysis of a childhood leukemia dataset.
Results and Discussion
ALG was used to genotyped a set of 95 SNPs in a cohort
consisting of 300 childhood acute lymphoblastic leukemia patients
and 329 healthy controls from the province of Quebec. Of these,
84 SNPs yielded distinct genotype clusters that were subsequently
validated by manual inspection, providing a 88% SNP to assay
conversion rate. We selected 3 SNPs based on the presence of
independent sequence analysis (Sanger sequencing) in order to
allow comparing genotypes obtained by ALG methods to those
coming from the sequencing experiment considered as true
genotypes. These 3 SNPs, rs2267437, rs828907 and rs11685387
were analyzed at blind. Genotypes were called twice, firstly in a
process totally automated by ALG using defaults setting and
secondly genotype calls were done manually. Manual calls can be
easily made by adjusting settings of the software using the GUI
(figure 1) based on graphical plot (figure 2) inspection of the data
clustering. Two of the SNPs were also genotyped in two
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19368independent experiments to allow testing the reproducibility of
calls. At the end the performance analysis consisted in approxi-
mately 9000 genotypes called.
Figure 3 provides an example of automated versus manual
genotype calling experiment. The fully automated method (when
the settings used are the default ones) is underestimating genotype:
at 95% confidence interval the NA calls (corresponding to no call)
are excessively high. Changing 95% to 99.99% had a huge impact
on the number of no-calls. Manually overwriting the automatic
cut-off for the SNP rs2267437 was necessary to get the proper
Figure 1. Graphical user interface provided in ALG. The Graphic User Interface (GUI) provided in the Automated Luminex Genotyping software
(ALG) allows effective management of the genotype calling process. The main interface of the GUI (a) is dedicated to input and output file
determination and to parameter selection. The confirmation interface (b) is used to verify parameter selection and to run the ALG analysis. The final
interface (c) informs the user of analysis completion.
doi:10.1371/journal.pone.0019368.g001
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minimal threshold could be influenced by the nucleotidic
composition surrounding the SNP which in turn could reduce
probe specificity. Chemistry of the beads in conjunction with
specific sequence can give shifted MFI (mean fluorescence
intensities) values. Nevertheless, a quick visual inspection of the
graph provides enough flexibility to obtain robust genotypes out of
these experiments. Table 1 gives a summary of the genotyping of
ALL data. Using a manual management of parameters ALG
reached an overall accuracy of 96.1% and a reproducibility of
94.1%. Here, the 4% of genotypes not correctly called is as a
majority composed of genotypes that are not called (2.6% of NA
and 0.8% of THR calls). Additionaly we compared 1100 calls
made by ALG on these three SNPs to those obtained using the
commercial MasterPlex GT suiteH (MiraiBio Group of Hitachi
Software Engineering America, Ltd. http://www.miraibio.com/
masterplex-gt/gt-overview.html). MasterPlex software gave an
overall accuracy of 89% whereas ALG reached 98% when the
software is used with a manual management of parameters. Thus
when a genotype is called by ALG, this call is highly accurate
(99.6%) and reproducible (99.8%). These high levels of reproduc-
ibility prove the robustness of the method to experimental
variations. Moreover they emphasized an important point where
experimental variation that can not be caught by the method will
lead to no calls and not to genotyping errors. Despite that manual
setting gives more accurate results than the use of default settings,
approximately 90% of results show similarity between the two
settings. Globally default settings developed based on our
experiments are sufficient to provide efficient calls (86.7% of
reproducibility and 93.9% of accuracy). However, we recommend
users to manually manage parameters: confidence level, threshold
value and cut-off value. At the end of the call procedure, it is also
possible to manually call unknown genotypes (no call). But once
manual adjustments are defined for a SNP, they can be
automatically re-used for the genotype call of other samples/
plates for the same SNP. The relevance of genotypes called by
ALG has been shown in a recent replication study [19].
Actually no freely available software has been proposed to
automate the genotype calling on the Luminex platform. In order
to overcome this situation, we propose the accurate ALG
clustering tool. ALG is semi-automated, requiring no prior
manual inspection of the microassay Luminex data, and provides
numerical measures of confidence for each SNP called, as well as
an effective graphical plot (Figure 2) of the data clustering for
visualization, optimization or troubleshooting purposes. As shown
by genotypes calls in leukemia cohort, ALG is highly accurate,
provides a very low no call threshold and performs very well when
compare to commercial software. Note that no-calls are mainly
affected by the confidence value and the cut –off definition. In
some cases, poor DNA quality will increase the level of no-call. But
in most cases, three well defined clusters were obtained leading to
accurate genotype calls.
Materials and Methods
Study subject
We investigated ALG performance by genotyping the Quebec
childhood acute lymphoblastic leukemia (ALL) cohort. The study
population has been previously described [20,21]. Our cohort
includes 189 boys and 132 girls with a median age of 4.7 years, all
French-Canadian from the province of Quebec, Canada. Parental
DNA was available for 203 of the probands. Healthy controls
(n=329) consisted of French-Canadian individuals. The CHU
Sainte-Justine Research Ethics Board approved the research
protocol and written consent was obtained from all participants
and/or their parents. DNA was isolated from buccal epithelial
cells, peripheral blood or bone marrow in remission as previously
described [22]. SNPs were genotyped using the Luminex xMAP/
Autoplex Analyser CS1000 system (Perkin Elmer, Waltham, MA).
Genetic variants were amplified using allele-specific primer
extension in multiplexed assays and hybridized to Luminex
MicroPlex TM –xTAG Microsperes as per Koo et al. [23].
Primer sequences for PCR amplification and for ASPE hybrid-
ization are given in Table S1 and S2 respectively. Amplification
conditions and reaction conditions are available upon request.
Implementation
Luminex assay analysis gives quantitative values that measure
the mean intensities of fluorescence of each allele. So for a SNP
marker with alleles A and B, which will give three possible
genotypes: AA, AB and BB, the mean intensities are vA and vB.
Individuals with genotype AA are expected to have high vA value
and low vB value. By contrast, individuals with genotype BB are
expected to have high vB value and low vA value. Individuals with
genotype AB are expected to have similar vA and vB values. vA
and vB values obtained for the 3 SNPs on a subset of the cohort
are given in the Table S3. To facilitate the genotype call, we
created a normalized value of intensity Q computed from vA and
vB value. Q is the ratio of vA reported on the sum of vA and vB:
Q~
vA
vAzvB
ðAÞ
Individuals with genotype AA will have an Q close to 1; an Q close
to 0 will correspond to individuals with BB genotype and
individuals with AB genotype will have an Q of approximately
0.5. Following genotyping of a large amount of individuals, this
approach will provide three clusters corresponding to pools of
individuals with the same genotype.
Figure 2. Graphical plot of data clustering. Data representation is
given as a plot of sum of luminosity on a log scale as a function of the
normalized luminosity for a C/T SNP genotyped in 91 individuals. The X
axis represents the normalized intensity Q, whereas the Y axis
represents the sum of the mean intensities of both probes, on a log
scale. Each point represents an individual genotype and points are
clustered in three groups based on genotype: CC (blue); CT (black); TT
(green); no-calls are shown in red. The brackets represent the
confidence interval boundaries for a type 1 error of 0.01. The silhouette
score (0.979) and HWE p-value (0.782) are also reported.
doi:10.1371/journal.pone.0019368.g002
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of each cluster and determining the individuals that belong to
them. An accurate definition of clusters will allow unbiased genetic
analyses. Ambiguous individuals located outside of clusters will be
automatically considered as no call. Four main features could
influence the clustering: (1) the cut-off definition allows groups to
be created with similar Q values; (2) the definition of the group
boundaries using the mean value and confidence interval method
to determine call accuracy; (3) each group of calls must undergo
quality controls to verify that there are no experimental or
mathematical aberrations that have biased the calling procedure;
(4) this approach must be applicable also to multi-allelic SNPs.
Defining the cut-offs. The cut-offs are two numerical values
(CoD and CoU) that are used to separate the possible range of
normalized values in three intervals: low values [0; CoD[,
intermediates values [CoD; CoU[and high values [CoU; 1].
High values will allow assignment of AA genotypes, intermediate
values for AB genotypes and low values for BB genotypes. The
ALG software provides two methods to compute cut-off values.
The first method is an arbitrary definition of the cut-offs where
CoD is equal to 0.3 and CoU to 0.7. The principle behind this
definition is to strictly follow the mathematical definition of
genotypes and do not consider experimental variations. In this
scenario one expects QAA values to be close to 1, QBB values to be
close to 0 and QAB values to be around 0.5 in order for the
intervals created by the arbitrary CoD and CoU values to
correctly discriminate between the three groups.
However, if experimental variation occurs, then the position of
three clusters can be skewed. For example a distribution of
clusters, where QAA values are close to 1, QBB values are around
0.3 and QAB values are around 0.75, is possible if the probe of the
A allele is more luminescent. In that case the theoretical definition
of cut-offs (0.3 and 0.7) is not accurate. So we develop in ALG a
second cut-off computation method that takes into account
experimental variability. For each SNP, the cut-off computation
is based on the maximum and the mean of the fluorescence
intensities measured for the two alleles as such:
CoU~
max vA ðÞ
max vA ðÞ zmin max vA ðÞ ,max vB ðÞ ,mean vA,vB ðÞ ½ 
CoD~
min max vA ðÞ ,max vB ðÞ ,mean vA,vB ðÞ ½ 
max vA ðÞ zmin max vA ðÞ ,max vB ðÞ ,mean vA,vB ðÞ ½ 
Max(vA) is the maximal vA value. The min[max(vA),max(vB),
mean(vA,vB)] term represents the minimal value of either the
maximal vA value, the maximal vB value or the mean value
computed on all vA and vB values (mean(vA,vB)). For the usual
situation in which all three genotypes are present, we expect that
a sufficient proportion of vA values are higher than vB values (for
AA genotypes) and a sufficient proportion of vB value are higher
than vA values (for BB genotypes). In that case, the range of vA
and vB is large and the mean of the overall value should be lower
than the maximum of both vA and vB. So the min[max(vA),-
max(vB),mean(vA,vB)] value will correspond to mean(vA,vB)
term. Thus cut-off values will be correlated to the ratio of the
global mean reported on the maximum of vA (mean-max ratio).
If measures are normally distributed and if probes has equivalent
fluorescent level, this ratio will be close to 1/2 (the mean is half
the maximum) and cut-off values close to 2/3 and 1/3 for CoU
and CoD, respectively. In that case, the experimental based cut-
off definition will approximate the arbitrary values (0.7 and 0.3).
However, if experimental specificities provide variation in the
mean-max ratio, the cut-off will follow this variation. For
example, if the mean-max ratios are equal to 1/3, 2/3 or 1 the
CoU values are 3/4, 3/5 and 1/2, respectively, showing the
limitation of arbitrary values. Note that the most important factor
that can influence the cut-off definition is the probe intensity
balance, a variation in the strength of intensity between the two
probes of a same SNP. In that case the default cut-off definition
will provide the most accurate estimates. On the other hand this
method will provide skewed cut-off values when genotyping
monoallelic SNPs and in that case the theoretical definition of
cut-off (0.7 vs 0.3) should be more appropriate. Finally, as
experimental variation can be unpredictable, the software also
Table 1. Summary of ALL data analysis.
Analysis information Count Overall %
Default vs. Manual 4013 4473 89.7
Reproducibility 1 - Default 1004 1330 75.5
Reproducibility 1 - Manual 1251 1330 94.1
Reproducibility 2 - Default 986 1137 86.7
Reproducibility 2 - Manual 1234 1236 99.8
NA calls - Default 142 4473 3.2
NA calls - Manual 118 4473 2.6
THR calls - Default 220 4473 4.9
THR calls - Manual 37 4473 0.8
Accuracy 1 - Default 3860 4473 86.3
Accuracy 1 - Manual 4299 4473 96.1
Accuracy 2 - Default 3860 4111 93.9
Accuracy 2 - Manual 4299 4318 99.6
Results represent a pooled analysis of the 3 SNPs comparing calls made using
either the default or manual settings of the software. The genotypes that can
not be called are sub-divided in two classes: NA calls which correspond to an
inappropriate normalized fluorescent value outside of confidence intervals and
THR calls, which correspond to raw fluorescence under the minimal threshold.
Accuracy, which represents the percent of ALG calls similar to the calls obtained
by sequencing experiments, and reproducibility are measured in each
condition. Reproducibility and accuracy are measured when all calls are taken
into account (1) or when only genotypic calls are considered (2, no Na and THR
calls). Measures are reported in terms of number of SNPs specifically called, the
overall number of SNPs called and the corresponding percentage.
doi:10.1371/journal.pone.0019368.t001
Figure 3. Manual versus automated genotype calls. An example of manual versus automated genotype calls obtained from the same assay is
provided for SNP rs2267437 (a and b), rs828907 (c and d) and rs11685387 (e and f). The X axis represents the normalized intensity Q, whereas the Y
axis value represents the logarithm of the sum, of the mean intensity of both probes. Automated calls (a, c and e) were obtained using the default
parameters of ALG: confidence a=0.05; minimum luminescent threshold =300 and default cut-off definition method. These parameters yield cut-off
values of 0.8/0.4, 0.6/0.3 and 0.7/0.2 respectively for rs2267437, rs828907 and rs11685387. Manual calls (b, d and f) were obtained with the following
user-defined parameters: confidence a=0.0001; minimum luminescent threshold =300; default cut-off definition method. These parameters yield
cut-off values of 0.6/0.3 and 0.7/0.2 respectively for rs828907 and rs11685387. Cut-off values for the SNP rs2267437 were set to 0.9/0.4 after visual
inspection of the results.
doi:10.1371/journal.pone.0019368.g003
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inputting a cut-off value file.
Defining the cluster boundaries. Using the two cut-off
values (CoU and CoD), normalized mean of intensity values Q are
separated into three groups: lower, median and higher. To ensure
that clusters are accurately defined, we computed confidence
intervals under a standard normal distribution using the following
formula:
IC1{a~  X X+ U1{a=2  
s X ðÞ
ﬃﬃﬃ
n
p
  
X represents the sample of intensities in each of the three groups
formed by the two cut-off values,   x x is the mean of X, s is the
standard deviation of X, n is the total sample size, a is the type I
error rate and U1-a/2 is the standard normal value for the quantile
1-a/2. As the normalization step shown in equation A induces
upper and lower limits of 0 to 1 for the range of Q values,
confidence intervals used to define the clusters in each group have
the same natural limits. Taking into account these limits, the lower
boundary of the lower group (BB genotypes) is limited at 0 and the
upper boundary of higher group (AA genotypes) is limited at 1.
Therefore confidence intervals are measured only for one
boundary of the AA group and for one boundary of the BB
group, whereas both upper and lower confidence interval
boundaries are computed for the median BA group. Thus we
can define the cluster boundaries for each genotype using the
confidence interval formula and removing the sample size term:
AA1{a~   X Xup{ U1{a   s Xup
     
;1
  
AB1{a~   X Xmed{ U1{a   s Xmed ðÞ ½  ;   X Xmedz U1{a   s Xmed ðÞ ½  ½ 
BB1{a~ 0;   X Xdownz U1{a   s Xdown ðÞ ½  ½ 
By default the type I error rate is 0.05, corresponding to the
commonly used threshold of significance. However, users are
allowed to modify a to reduce or increase the cluster stringency.
Note that normalized intensities were approximated with a normal
distribution. This implies that for analysis to be performed, certain
conditions (such as independency and identical-distribution with
finite variance) should be met. We considered that the conditions
are met when the normalization was done on sample of a size
higher or equal than 30 individuals for each SNP (the principle of
the central limit theorem). For smaller sample size, normalized
intensities will not follow a normal distribution implying that both
cut-offs and confidence intervals could not be applicable. In that
case, ALG software will still provide genotyping calls but they will
come with warning messages that inform users of the possible non-
normality of the data.
Quality controls. We further developed the software to
control for quality of genotype calls. ALG currently offers six
quality control tools. First, ALG controls the minimum threshold
of fluorescence, which represents the minimum measure for each
individual to be considered as a potential call. For a given SNP, if
the sum of the mean intensity for each probe is lower than a
minimum threshold of fluorescence, then the genotype calling of
these individuals will not be considered in the analysis and the
value THR (for minimum threshold) is returned as call. Based on
experimental tests the minimal threshold has been fixed to 300 by
default; however users are allowed to adjust it in function of their
specific experimental conditions.
The next quality control tool of ALG is used only when more
than 80% of individuals are found in the same cluster. Using this
tool, ALG has the power to investigate whether experimental
artefact has biased the analyses. To do so, we perform a second
round of computations of the cut-off values and confidence
interval boundaries using only the individuals found in this cluster.
Clustering of these individuals validates the first round of
computation, which indicates that the initial clustering was
correct. Grouping of the individuals in different clusters shows
that individuals are not homogeneous and need to be divided into
different groups. This cancels the first analysis and we continue the
analysis using the second cut-off values. New confidence interval
boundaries are computed using these new cut-off values and all the
individuals used for the first analysis.
ALG also contains mathematical quality control tools. During
the analysis, it is important to avoid overlap in different clusters.
Overlapping cluster will result in two different genotypes for an
individual and thus lead to a no call genotype. In case of overlap,
the boundaries of the two clusters are moved to create flanking
confidence intervals. The break point between the two clusters is
determined as the point located at equidistance from the old
overlapping boundaries. Limiting the cut-off deviation from the
expected 0.3 and 0.7 values is crucial for the analysis. To consider
the presence of three possible clusters, the CoU is limited to values
higher than 0.6 and CoD to values lower than 0.4. These
mathematical controls are essential in order to both limit the
accumulation of no calls and to avoid extreme values created by
experimental variation that can bias the analysis.
Finally, the software has quality control tools that are post
calling controls that verify the robustness of the genotype calls.
These controls correspond to the computation of both the
Silhouette scores [24] and Hardy-Weinberg equilibrium tests.
Using a Silhouette calculation, we can determine the distance from
each data point in a cluster to all other data points within the same
cluster and to all data points in the closest cluster. Thus this
calculation provides a measure of how well a data point is classified
when it is assigned to a given cluster according to both the
tightness of the clusters and the separation between them [25].
The Silhouette score condenses the cluster quality for each SNP
assay into a single measure that ranges from 1 to -1. It is
recommended to accept the results from SNP assays with
Silhouette scores .0.65, to fail the whole assays if the Silhouette
scores is ,0.25 and to manually inspect the assay results if the
score is included in the [0.25; 0.65] interval. ALG also performs a
Hardy-Weinberg equilibrium test. This test is a Pearson’s chi-
squared test, using the observed genotype frequencies obtained
from the genotype calling and the expected genotype frequencies
under Hardy-Weinberg proportions. The quality of the data is
reported in terms of type I error. As the Hardy-Weinberg
equilibrium test could be biased in the case where SNPs chosen to
be genotyped are correlated to the sample ascertainment, the
Hardy-Weinberg quality controls is only given for information
purpose and the corresponding rejection of SNPs must results
from detailed inspection of the data and of the assay design. Note
that a bias in Hardy-Weinberg equilibrium is possible when one
tries to genotype SNPs associated to a disease in a set of individuals
that have develop the disease. In which case, we would expect the
genotype distribution in individuals not to follow the Hardy-
Weinberg proportion due to the correlation between the SNPs and
the disease. Thus, to reduce this possible bias we recommend
mixing cases and controls in the same assay.
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calling algorithms is dealing with multi-allelic SNPs. Ignoring
multi-allelic SNPs could leads to bias genetic association studies
[26]. Multi-allelic SNPs represent approximately 1% of SNPs
found in Ensembl release 43. In ALG multi-allelic SNPs are
processed in a very simple manner. ALG creates subgroups of
individuals based on the two most fluorescent probes. Then each
subgroup is analyzed based on genotyping a biallelic SNP. For
example, if one genotype a SNP with three alleles A, B and C,
ALG creates three subgroups of individuals: 1) individuals who are
analyzed for alleles A and B (genotypes AA, AB and BB); 2)
individuals who are analyzed for alleles A and C (genotypes AA,
AC and CC) and 3) individuals who are analyzed for alleles B and
C (genotypes BB, BC and CC). Figure 4 shows an example of
Figure 4. Genotype calls of the multi-allelic SNP rs2069416. ALG analysis of the multi-allelic SNP rs2069416. SNP rs2069416 has three alleles A,
T and G leading to three independent genotype calling procedures: A vs T, A vs G and G vs T. The procedure in which an individual is analyzed
depends on its two most luminescent probes. The X axis represents the normalized intensity Q, whereas the Y axis value represents the sum of the
mean intensity of both probes on the log scale. Genotype calls are obtained using user-specific parameters of ALG: confidence a=0.05; minimum
luminescent threshold =200; default cut-off definition method. These parameters give cut-off values of 0.6/0.3 and 0.7/0.4 respectively for A vs G and
G vs T procedures. Cut-off values for the A vs T were set to 0.7/0.3 after visual inspection of the results.
doi:10.1371/journal.pone.0019368.g004
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method to deal with multi-allelic SNPs is very accurate because
each individual carried only two alleles and probes other than the
two most fluorescent ones can be consider as background noise. As
multiple allele procedure does not consider the entire set of
individuals in the same analysis, Hardy-Weinberg quality control
was not applied. Note that the method is limited by the minimal
sample size (30 individuals) required for each sub-group to stay
under the normality assumption that validate cut-offs and
confidence intervals computation.
Availability and Future Directions
Additional improvement should be done to both increase the
efficiency of software and reduce the manual management of the
software parameters. The high efficiency of the ALG algorithm,
proven by the analysis of real data, makes also conceivable to
adapt it to other genotyping platforms. The ALG package
provides an implementation of this tool in the open source R
programming environment that will promote additional develop-
ment either by actual developers or by external users. Finally the
ALG GUI allows a user friendly interface to input data and run
analyses without specific informatics knowledge. ALG is actually
available for both windows and Linux/Unix operating systems at
the project home page: http://sourceforge.net/projects/alg.
Supporting Information
Table S1 PCR amplification primers. The PCR amplifi-
cation primers and the size of the fragment generated using these
primers are given for the 3 SNPs included in the performance
analysis.
(DOCX)
Table S2 ASPE hybridization primers. The ASPE hybrid-
ization primers and the corresponding bead number on the assay
are given for the 3 SNPs included in the performance analysis.
The lowercase sequence represents the part of the primer
sequence specific to the bead whereas the uppercase sequence
characterises the SNP locus. The SNP allele corresponds to the last
base of the primer sequence represented here in bold. * indicates
uppercase sequences designed from the reverse strand.
(DOCX)
Table S3 Median FMI values and genotype call. The
median MFI values obtain from the Lunminex analysis with
standard sensitivity are provided for the 3 SNPs included in the
performance analysis. The values are available for a subset of 38
control individuals. For each SNP and each individual the median
MFI values are given for both the reference and the variant
probes. The corresponding individual’s genotype determined by
the ALG software is represented through the background colour of
the cells. Blue cells indicate homozygote reference calls, pink cells
represents homozygote variant calls and orange cells correspond to
heterozygote calls. White cells are used to identify no-calls (THR;
NA call or blank negative controls).
(DOCX)
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